[1]马志刚.瑞格列奈联合罗格列酮对糖尿病患者血清HbA1c、IL-6、TNF-α水平的影响[J].医学信息,2021,34(12):9-11.[doi:10.3969/j.issn.1006-1959.2021.12.003]
　MA Zhi-gang.The Effect of Repaglinide Combined with Rosiglitazone on Serum HbA1c,IL-6 and TNF-α Levels in Diabetic Patients[J].Medical Information,2021,34(12):9-11.[doi:10.3969/j.issn.1006-1959.2021.12.003]
点击复制

瑞格列奈联合罗格列酮对糖尿病患者血清HbA1c、IL-6、TNF-α水平的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年12期
页码:
9-11
栏目:
出版日期:
2021-06-15

文章信息/Info

Title:
The Effect of Repaglinide Combined with Rosiglitazone on Serum HbA1c,IL-6 and TNF-α Levels in Diabetic Patients
文章编号:
1006-1959（2021）12-0009-03
作者:
马志刚
（天津市人民医院药学部，天津 300121）
Author(s):
MA Zhi-gang
(Department of Pharmacy,Tianjin People’s Hospital,Tianjin 300121,China)
关键词:
瑞格列奈; 罗格列酮; 糖尿病; HbA1c; IL-6; TNF-α
Keywords:
Repaglinide; Rosiglitazone; Diabetes; HbA1c; IL-6; TNF-α
分类号:
R587.1
DOI:
10.3969/j.issn.1006-1959.2021.12.003
文献标志码:
A
摘要:
目的 探讨瑞格列奈联合罗格列酮对糖尿病患者血清HbA1c、IL-6、TNF-α水平的影响。方法 选取2018年1月~2020年1月我院收治的糖尿病患者102例为研究对象，采用随机数字表法分为对照组和研究组，各51例，对照组应用瑞格列奈治疗，研究组在对照组基础上联合罗格列酮治疗，比较两组临床治疗总有效率、炎性指标水平、血脂指标水平、血糖水平以及不良反应发生情况。结果 研究组总有效率为54.90%，高于对照组的37.30%，差异有统计学意义（P＜0.05）；研究组IL-6、CRP、TNF-α水平均低于对照组，差异有统计学意义（P＜0.05）；研究组HbA1c、LDL-C、2hFPG水平低于对照组，HDL-C水平高于对照组，差异有统计学意义（P＜0.05）；研究组FPG低于对照组，BMI高于对照组，差异有统计学意义（P＜0.05）；研究组不良反应发生率为7.80%，低于对照组的23.50%，差异有统计学意义（P＜0.05）。结论 瑞格列奈联合罗格列酮治疗糖尿病效果确切，可减少不良反应，改善血清HbA1c、IL-6、TNF-α水平。
Abstract:
Objective To investigate the effect of repaglinide combined with rosiglitazone on serum HbA1c, IL-6 and TNF-α levels in diabetic patients.Methods A total of 102 diabetic patients admitted to our hospital from January 2018 to January 2020 were selected as the research objects.The random number table was used to divide the control group and the study group, each with 51 cases. The control group was treated with repaglinide, and the study group was treated with rosiglitazone on the basis of the control group. The total effective rate and inflammation of the two groups were compared. Sex index level, blood lipid index level, blood sugar level and occurrence of adverse reactions.Results The total effective rate of the study group was 54.90%, which was higher than 37.30% of the control group,the difference was statistically significant (P＜0.05);The levels of IL-6, CRP, and TNF-α in the study group were lower than those in the control group,the difference was statistically significant(P＜0.05);The levels of HbA1c, LDL-C, and 2hFPG in the study group were lower than those in the control group, and the levels of HDL-C were higher than those in the control group,the difference was statistically significant (P＜0.05);The FPG of the study group was lower than that of the control group, and the BMI was higher than that of the control group, the difference was statistically significant (P＜0.05);The incidence of adverse reactions in the study group was 7.80%, which was lower than 23.50% in the control group,the difference was statistically significant(P＜0.05).Conclusion Repaglinide combined with rosiglitazone has a definite effect in the treatment of diabetes. It can reduce adverse reactions and improve serum HbA1c, IL-6, and TNF-α levels.

参考文献/References:

[1]郭建.止渴养阴胶囊联合罗格列酮治疗2型糖尿病的临床研究[J].现代药物与临床,2019,34(9):2786-2789. [2]周武强.二甲双胍联合罗格列酮治疗2型糖尿病的临床效果[J].中国社区医师,2019,35(21):73-74. [3]Irak K,Yildirim S,Mert H,et al.Grape seed extract effects on serum amylase levels and immunohistochemical alterations in Streptozotocin-induced diabetic rats[J].Cell Mol Biol(Noisy-le-grand),2018,64(4):92-97. [4]王鹏,杨蕊,崔学艳,等.罗格列酮对比二甲双胍治疗2型糖尿病有效性和安全性的系统评价[J].中国药房,2015,26(27):3797-3799. [5]朱亭,邓月珍,季正香,等.利拉鲁肽对初诊肥胖2型糖尿病患者血清nesfatin-1和炎性指标的影响[J].国际内分泌代谢杂志,2018,38(6):366. [6]Su JB,Zhao LH,Zhang XL,et al.High-normal serum thyrotropin levels and increased glycemic variability in type 2 diabetic patients[J].Endocrine,2018,1(1):1-8. [7]何慧,秦洁,杨艳兰.阿卡波糖联合二甲双胍治疗糖尿病合并冠心病的效果及对机体血清炎性因子和心功能的影响[J].中国实用医刊,2018,45(21):86. [8]宋秋萍,胡淼.GLP-1类似物联合阿卡波糖对肥胖2型糖尿病患者血清Chemerin、Visfatin、HbA1c水平的影响[J].中国医师杂志,2018,20(12):1858-1860. [9]June F,Howe J,Rich J,et al.Lessons from the Real World: Financial Incentives to Improve Glycemic Control in Patients with Type 2 Diabetes[J].Health,2018,10(2):171-180. [10]钟燕玲,梁采平,刘俏敏.甘精胰岛素、瑞格列奈治疗糖尿病对临床效果及氧化应激指标的影响比较[J].中国医学创新,2019,11(23):64-68. [11]闫桃荣.应用罗格列酮和二甲双胍治疗肥胖型2型糖尿病的效果评价[J].中西医结合心血管病电子杂志,2018,6(12):167-168. [12]Fiorentino TV,Sesti F,Succurro E,et al.Higher serum levels of uric acid are associated with a reduced insulin clearance in non-diabetic individuals[J].Acta Diabetol,2018,55(2):1-8. [13]牛先学.舒洛地特联合瑞格列奈对糖尿病肾病患者糖脂代谢及肾功能的影响[J].实用糖尿病杂志,2019,16(1):23-24. [14]李婉妮.降糖舒片联合瑞格列奈治疗2型糖尿病的临床研究[J].现代药物与临床,2019,34(12):3696-3699. [15]Choi YJ,Ock SY,Jin Y,et al.Urinary Pentosidine levels negatively associates with trabecular bone scores in patients with type 2 diabetes mellitus[J].Osteoporos Int,2018,29(1):1-9.

相似文献/References:

[1]高艳红,哈海枫,陈小军,等.甘精胰岛素联合瑞格列奈治疗老年2型糖尿病的临床效果[J].医学信息,2021,34(01):152.[doi:10.3969/j.issn.1006-1959.2021.01.041]
　GAO Yan-hong,HA Hai-feng,CHEN Xiao-jun,et al.Clinical Effect of Insulin Glargine Combined with Repaglinide in the Treatment of Elderly Type 2 Diabetes[J].Medical Information,2021,34(12):152.[doi:10.3969/j.issn.1006-1959.2021.01.041]

更新日期/Last Update: 1900-01-01